Product Information File: Why the Toxicologist Plays a Central Role in Cosmetic Safety

Product Information File structure for cosmetic products showing key components including safety assessment, formulation data and regulatory documentation.

The Product Information File, commonly referred to as the PIF, is one of the cornerstone documents required to demonstrate the safety and regulatory compliance of cosmetic products in the European Union. Under the provisions of the Regulation (EC) No 1223/2009, every cosmetic product placed on the market must be supported by a complete and up […]

Safety Data Sheets: Regulatory Requirements, Compliance and Chemical Risk Management

Safety Data Sheets, commonly referred to as SDSs, are essential regulatory documents for communicating information on chemical hazards, safe handling, exposure controls and emergency measures. An accurate and up to date SDS supports regulatory compliance, occupational safety and effective chemical risk management throughout the supply chain. The regulatory requirements governing Safety Data Sheets vary across […]

ToxHub at EUROTOX 2026 | Booth 58 and QSAR Poster

Chiara Gazerro representing ToxHub at EUROTOX 2026 in Vienna, available at booth 58 together with SenzaGen

ToxHub at EUROTOX 2026: Meet our Chiara Gazerro at Booth 58 ToxHub is pleased to announce its participation in EUROTOX 2026, one of Europe’s leading international congresses dedicated to toxicology. TThe congress will take place from 13 to 16 September 2026 at the Austria Center Vienna in Vienna, Austria. Under the theme “Toxicology without borders”, […]

FDA Partial Recognition of EN ISO 10993-1:2025

FDA partial regonition of ISO 10993-1. Alignement with ISO 14971 and risk estimation

The FDA officially recognized EN ISO 10993-1:2025 – “Biological evaluation of medical devices – Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process” on Monday, May 25, 2026. However, the Agency granted only a partial recognition! The 6th edition of ISO 10993-1 has been reshaped with a stronger […]

Non-Genotoxic Impurities Qualification: A Risk Based and Scientifically Justified Approach

The control and qualification of impurities remain among the most critical aspects in the development and lifecycle management of pharmaceutical products. However, the recently published reflection paper from the European Medicines Agency signals an important evolution in how non-genotoxic impurities should be assessed, justified, and managed during pharmaceutical development. Until recently, qualification of non-genotoxic impurities […]

ISO 10993-1 – What’s New in medical devices Biological Evaluation?

Biological evaluation process for medical devices according to ISO 10993-1 within a risk management framework across the device life cycle

The 6th version of ISO 10993 – Biological evaluation of medical devices — Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process has been released! With the entry into force of Medical Devices Regulation (EU) 2017/745 (MDR), the approach to safety has become even more stringent, especially […]